PubRank

L K Ashman

Author PubWeight™ 71.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993 3.57
2 Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions. J Cell Biol 1998 2.06
3 The use of alkaline phosphatase-conjugated anti-immunoglobulin with immunoblots for determining the specificity of monoclonal antibodies to protein mixtures. Methods Enzymol 1986 1.86
4 Application of the nitrocellulose transfer technique and alkaline phosphatase conjugated anti-immunoglobulin for determination of the specificity of monoclonal antibodies to protein mixtures. J Immunol Methods 1982 1.76
5 Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and alpha5beta1 integrin. J Histochem Cytochem 1997 1.73
6 A platelet tetraspanin superfamily member, CD151, is required for regulation of thrombus growth and stability in vivo. J Thromb Haemost 2009 1.55
7 PETA-3/CD151, a member of the transmembrane 4 superfamily, is localised to the plasma membrane and endocytic system of endothelial cells, associates with multiple integrins and modulates cell function. J Cell Sci 1999 1.47
8 Expression of a functional c-kit receptor on a subset of natural killer cells. J Exp Med 1993 1.45
9 Biotinylation: an alternative to radioiodination for the identification of cell surface antigens in immunoprecipitates. Mol Immunol 1987 1.42
10 Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 1991 1.40
11 Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood 1989 1.33
12 Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992 1.28
13 Molecular cloning of cDNA encoding a novel platelet-endothelial cell tetra-span antigen, PETA-3. Blood 1995 1.21
14 Sheep kidney pyruvate carboxylase. Studies on its activation by acetyl coenzyme A and characteristics of its acetyl coenzyme A independent reaction. J Biol Chem 1972 1.18
15 Transmembrane 4 superfamily protein CD151 (PETA-3) associates with beta 1 and alpha IIb beta 3 integrins in haemopoietic cell lines and modulates cell-cell adhesion. Biochem J 1999 1.17
16 Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts. Oncogene 1999 1.09
17 A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells. Blood 1994 1.09
18 Sheep kidney pyruvate carboxylase. Studies on the coupling of adenosine triphosphate hydrolysis and CO2 fixation. J Biol Chem 1975 1.06
19 Microfibril-associated glycoprotein-2 specifically interacts with a range of bovine and human cell types via alphaVbeta3 integrin. J Biol Chem 1999 1.04
20 Comparative analysis of signaling pathways between mast cell growth factor (c-kit ligand) and granulocyte-macrophage colony-stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of Raf-1, GTPase-activating protein and mitogen-activated protein kinase. Exp Hematol 1991 1.00
21 IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J Immunol 1991 0.98
22 Specificity of a mouse monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in human mucosal and connective tissues. Immunol Cell Biol 1987 0.96
23 Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT. Br J Dermatol 2008 0.95
24 A powerful new technique for isolating genes encoding cell surface antigens using retroviral expression cloning. J Immunol 1996 0.95
25 Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1). J Invest Dermatol 1994 0.94
26 AMP deaminase from rabbit skeletal muscle: the effect of monovalent cations on catalytic activity and molecular weight. Biochim Biophys Acta 1972 0.93
27 The mobilization of primitive hemopoietic progenitors into the peripheral blood. Stem Cells 1994 0.93
28 Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line. Leukemia 1994 0.92
29 Proliferative response of normal and activated human lymphocytes to tetradecanoyl phorbol acetate. Cell Immunol 1984 0.89
30 Assessment of the anti-c-kit monoclonal antibody YB5.B8 in affinity magnetic enrichment of human lung mast cells. J Immunol Methods 1994 0.89
31 Increased expression of c-Kit or its ligand Steel Factor is not a common feature of adult acute myeloid leukaemia. Leukemia 1996 0.88
32 Enforced expression of full length c-Myb leads to density-dependent transformation of murine haemopoietic cells. Oncogene 1995 0.87
33 c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture. Exp Hematol 1994 0.87
34 Internalization of Kit together with stem cell factor on human fetal liver-derived mast cells: new protein and RNA synthesis are required for reappearance of Kit. J Immunol 1996 0.86
35 Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor. Cell Growth Differ 1996 0.86
36 Densitization of pyruvate carboxylase against acetyl-CoA stimulation by chemical modification. Biochem Biophys Res Commun 1973 0.86
37 Interleukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 1994 0.85
38 Responses of the murine myeloid cell line FDC-P1 to soluble and membrane-bound forms of steel factor (SLF). Exp Hematol 1993 0.85
39 Differential tissue expression of epitopes of the tetraspanin CD151 recognised by monoclonal antibodies. Tissue Antigens 2001 0.84
40 Immobilized anti-KIT monoclonal antibody induces ligand-independent dimerization and activation of Steel factor receptor: biologic similarity with membrane-bound form of Steel factor rather than its soluble form. Blood 1996 0.83
41 Binding of mouse monoclonal antibodies to human leukaemic cells via the Fc receptor: a possible source of 'false positive' reactions in specificity screening. Clin Exp Immunol 1983 0.83
42 Two-stage skin carcinogenesis in sensitive and resistant mouse strains. Carcinogenesis 1982 0.83
43 Phenotypic characterization of stem cell factor-dependent human foetal liver-derived mast cells. Immunology 1993 0.82
44 Effect of Salmonella enteritidis 11RX infection on two-stage skin carcinogenesis in mice. Aust J Exp Biol Med Sci 1978 0.82
45 Expression of constitutively activated human c-Kit in Myb transformed early myeloid cells leads to factor independence, histiocytic differentiation, and tumorigenicity. Blood 1997 0.82
46 Expression of c-Kit and functional drug efflux are correlated in de novo acute myeloid leukaemia. Leukemia 1997 0.82
47 Physicochemical and immunochemical properties of carcinoembryonic antigen (CEA) from different tumour sources. Aust J Exp Biol Med Sci 1978 0.81
48 Specificity and functional effects of antibodies to human stem cell factor. Growth Factors 1997 0.80
49 Transformation of NIH3T3 fibroblasts by the c-Kit receptor tyrosine kinase: effect of receptor density and ligand-requirement. Oncogene 1998 0.80
50 Characterisation of the mouse homologue of CD151 (PETA-3/SFA-1); genomic structure, chromosomal localisation and identification of 2 novel splice forms. Biochim Biophys Acta 1998 0.80
51 Retracted Functional expression of c-kit by acute myelogenous leukemia blasts is enhanced by tumor necrosis factor-alpha through posttranscriptional mRNA stabilization by a labile protein. Blood 1992 0.79
52 Comparison of whole plasma and perchloric acid-extracted plasma assays for carcinoembryonic antigen. Clin Chim Acta 1977 0.79
53 Expression of the non-T ALL-associated p24 antigen on leukaemic blasts from patients with ANLL. Leuk Res 1987 0.79
54 Platelet activation induced by a murine monoclonal antibody directed against a novel tetra-span antigen. Br J Haematol 1995 0.79
55 Specificity of the passive antibody-induced suppression of the humoral immune response of mice to surface antigens on human cells. Immunology 1985 0.79
56 Human mast cells derived from fetal liver cells cultured with stem cell factor express a functional CD51/CD61 (alpha v beta 3) integrin. Blood 1995 0.79
57 A kinetic approach to defining the role of chemically modifiable residues at the active sites of enzymes. Aust J Biol Sci 1975 0.79
58 Factors affecting the ability of various strains of Enterobacteriaceae to induce tumour resistance in mice. Aust J Exp Biol Med Sci 1980 0.78
59 Human myeloid differentiation antigens identified by monoclonal antibodies to the myelomonocytic leukemia cell line RC-2A. Pathology 1988 0.77
60 The effect of recombinant cytokines on the proliferative potential and phenotype of cells of the human myelomonocytic leukaemia line, RC-2A. Leuk Res 1988 0.77
61 Downregulation of c-kit (stem cell factor receptor) in transformed hematopoietic precursor cells by stroma cells. Blood 1999 0.77
62 Characterization of c-kit expression by primitive hematopoietic progenitors in umbilical cord blood. Exp Hematol 1995 0.77
63 Stem cell factor-induced downregulation of c-kit in human lung mast cells and HMC-1 mast cells. Exp Hematol 1996 0.77
64 Human lung mast cells are enriched in the capacity to produce granulocyte-macrophage colony-stimulating factor in response to IgE-dependent stimulation. Eur J Immunol 1998 0.77
65 Small molecule inhibitors of protein kinases in cancer- how to overcome resistance. Mini Rev Med Chem 2006 0.76
66 Surface antigen expression by a human B-lymphoblastoid cell line treated with 'differentiation' inducers, dimethysulfoxide and tetradecanoylphorbol acetate. Leuk Res 1985 0.76
67 Activation of eosinophils with cytokines produced by lung mast cells. Int Arch Allergy Immunol 1997 0.76
68 A monoclonal antibody to a human mast cell/myeloid leukaemia-specific antigen binds to normal haemopoietic progenitor cells and inhibits colony formation in vitro. Leuk Res 1988 0.76
69 Variations in antigen expression during the cell cycle of a human B-lymphoblastoid cell line. Leuk Res 1985 0.76
70 HL-60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: analysis of the responding population and mechanism of cytotoxic lymphocyte activation. Immunology 1996 0.75
71 Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor. Immunology 1995 0.75
72 Probabilistic application of plasma carcinoembryonic antigen assay in cancer patients. Br Med J 1975 0.75
73 Relationship between c-Kit expression and proliferation in acute myeloblastic leukemia cell lines. J Cell Physiol 1993 0.75
74 Inhibition of the growth of Lewis lung carcinoma in syngeneic mice by Salmonella antigens. Aust J Exp Biol Med Sci 1979 0.75
75 The expression of mature myeloid cell differentiation markers in acute leukemia. Pathology 1987 0.75
76 Stimulatory ability of human leukaemic cells in the allogeneic mixed leucocyte reaction. Aust J Exp Biol Med Sci 1983 0.75
77 Transfection of genes for human cell surface antigens identified by monoclonal antibodies. Immunol Cell Biol 1989 0.75
78 A murine monoclonal antibody specific for a cell-surface antigen expressed by a subgroup of human myeloid leukaemias. Leuk Res 1985 0.75
79 Synergistic action of interleukin-2 and Steel factor (SLF) on a human T lymphoblastoid cell line. Leukemia 1995 0.75
80 Protective effect of oral Salmonella enteritidis 11RX infection against colon tumor induction by 1,2-dimethylhydrazine in mice. Cancer Res 1979 0.75
81 Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro. Exp Hematol 1993 0.75
82 A comparison of three blood tests for cancer. Surg Gynecol Obstet 1980 0.75
83 Hepatitis B virus binding to leucocyte plasma membranes utilizes a different region of the preS1 domain to the hepatocyte receptor binding site and does not require receptors for opsonins. Immunol Cell Biol 1997 0.75
84 The Rose Bengal assay for monoclonal antibodies to cell surface antigens: comparisons with common hybridoma screening methods. J Immunoassay 1985 0.75
85 Autologous responses to human leukaemic cells in mixed leucocyte culture. Cancer Immunol Immunother 1986 0.75
86 Immunological competence of patients in remission from acute leukaemia: apparently normal T cell function but defective pokeweed mitogen-driven immunoglobulin synthesis. Immunol Cell Biol 1987 0.75
87 Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product. J Immunol 1993 0.75
88 Involvement of donor lymphoreticular cells in the rejection of B16 melanoma by allogeneic mice. Aust J Exp Biol Med Sci 1980 0.75
89 Immunoadsorbent purification of the carcinoembryonic antigen. Immunochemistry 1977 0.75
90 Studies on the differentiation of the human myelomonocytic cell line RC-2A in response to lymphocyte-derived factors. Leuk Res 1987 0.75